EC Number   |
Activating Compound |
Reference |
|---|
   3.4.21.21 | factor Xa |
activates |
654583 |
| 3.4.21.21 | factor Xa |
activates the tissue factor-VII complex |
717385 |
| 3.4.21.21 | Herpes simplex virus 1 encoded glycoprotein C |
gC, 1000fold activity-enhancing effect in the absence of tissue factor and in the presence of 5 mM Ca2+ and 0.1 mM synthetic small unilamellar vesicles composed of 75% phosphatidylcholine and 25% phosphatidylserine |
670935 |
| 3.4.21.21 | Janus kinase 2 |
- |
668259 |
| 3.4.21.21 | more |
enzyme activation involves residue 343, mechanisms, overview |
683347 |
| 3.4.21.21 | more |
the relative catalytic efficiency is increased 170 and 150fold in the presence of saturating amounts of monoclonal antibodies F36 and F37, respectively |
732085 |
| 3.4.21.21 | phospholipid vesicle |
oleoyl-1,2-diacyl-sn-glycero-3-phosphocholine and dioleoyl-1,2-diacyl-sn-glycero-3-(phospho-L-serine) |
667680 |
| 3.4.21.21 | protease-activated receptor-2 |
1.5fold activity enhancement |
668158 |
| 3.4.21.21 | tissue factor |
- |
667584, 667668, 667680, 668304, 669484, 670055, 718044, 731271, 732156, 732339 |
| 3.4.21.21 | tissue factor |
60fold to 100fold enhancement of amidolytic efficiency |
670270 |
